GlassScriptPhysician profile
Muhammad Farhan Nadeem
NPI 1639585078
$12,311.62
in general payments reported to CMS, 2019-2025
26 companies · $3,362 in 2025
The $3,362 reported for 2025 was more than what 76% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2021: $761 · 2022: $3,536 · 2023: $2,618 · 2024: $1,213 · 2025: $3,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,617 · Food and Beverage: $3,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,616.50 |
| Food and Beverage | $3,576.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,536.38 | 2022-2025 | Da Vinci Surgical System |
| Edwards Lifesciences Corporation | $3,016.34 | 2021-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Atricure, INC. | $2,105.56 | 2021-2023 | |
| Boston Scientific Corporation | $840.25 | 2019-2024 | Bodyguardian |
| Artivion, INC. | $628.83 | 2025 | Amds-Ascyrus Medical |
| Abiomed | $548.78 | 2022-2025 | Impella |
| Abbott Laboratories | $438.49 | 2022-2023 | Epic |
| Ambu INC. | $223.33 | 2024 | |
| Angiodynamics, INC. | $181.48 | 2021 | |
| Medtronic, INC. | $101.01 | 2021-2024 | Na |
| Amgen INC. | $97.57 | 2023-2025 | Repatha, Repatha |
| Medistim USA, INC. | $92.85 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.25 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $62.77 | 2023-2025 | Verquvo, Winrevair |
| Baxter Healthcare | $62.54 | 2025 | Coseal, Perclot, Preveleak |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $45.39 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $43.60 | 2024 | |
| Livanova USA, INC. | $38.97 | 2025 | Essenz |
| Janssen Pharmaceuticals, INC | $36.10 | 2023 | Xarelto |
| Heartflow, INC. | $35.24 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $29.44 | 2025 | Evkeeza |
| Kls-Martin L.P. | $21.85 | 2024 | |
| Getinge USA Sales, LLC | $17.96 | 2025 | Cardiohelp |
| Novo Nordisk INC | $14.95 | 2023 | Wegovy |
| W. L. Gore & Associates, INC. | $14.40 | 2023 | Gore Cardioform Septal Occluder |
| Astrazeneca Pharmaceuticals LP | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Farhan Nadeem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.